Anti-Human ADAM17 Therapeutic Antibody (B07)
The anti-ADAM17 antibody target ADAM17, also known as TACE (TNF-alpha converting enzyme), which was known to be important drivers of tumorigenesis and to promote resistance to existing therapeutics. By inhibiting the activity of ADAM17, the antibody can be used in the treatment of cancers such as NSCLC and breast cancer.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-0667CLV |
| Pricing | Inquiry |
| Type | Fully Human antibody |
| Host | Human |
| Target | ADAM17 |
| Species Reactivity | Cross-react with mouse ADAM17 |